SHAREHOLDERS' EQUITY | NOTE 9: - SHAREHOLDERS' EQUITY Share-based compensation: a. On October 30, 2016, the Board resolved to increase the number of Ordinary Shares reserved under the 2013 Share Option Plan from 1,250,000 to 2,450,000. The total number of Ordinary Shares available for future grants under the 2013 Share Option Plan as of June 30, 2019 was 712,225. b. The following is a summary of the Company's stock options activity for the six month period ended June 30, 2019: Number of options Weighted-average exercise price Weighted- average remaining contractual term Aggregate intrinsic value Outstanding at January 1, 2019 415,510 $ 14.62 2.69 $ 3 Granted - - Exercised (1,500 ) 6.00 Expired and forfeited (17,400 ) 15.99 Outstanding at June 30, 2019 396,610 $ 14.59 2.20 $ 2 Vested and expected to vest at June 30, 2019 396,610 $ 14.59 2.20 $ 2 Exercisable at June 30, 2019 230,884 $ 12.92 1.78 $ 2 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the fair value of the Company's Ordinary Shares on the last day of the six month period ended June 30, 2019 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on June 30, 2019. This amount is impacted by the changes in the fair market value of the Company's Ordinary Shares. c. As of June 30, 2019, stock options under the 2013 Share Option Plan, as amended are as follows: Options outstanding at Options exercisable at Exercise price Number outstanding Weighted average exercise price Weighted average remaining contractual life Number exercisable Weighted average exercise price Weighted average remaining contractual life $ $ In years $ In years 6.00 750 6.00 0.06 750 6.00 0.06 11.12-14.52 251,708 11.87 1.72 195,133 11.88 1.63 18.90-19.85 144,152 19.39 3.05 35,001 18.90 2.64 396,610 230,884 d. The following is a summary of the Company's restricted stock unit ("RSU") activity for the six month period ended June 30, 2019: Number of RSUs Weighted average remaining contractual term Aggregate intrinsic value Outstanding at January 1, 2019 168,869 1.40 $ 1,253 Granted 263,220 Vested (36,244 ) Cancelled and forfeited (10,800 ) Outstanding at June 30, 2019 385,045 1.81 $ 3,169 Vested and expected to vest at June 30, 2019 385,045 1.81 $ 3,169 e. The weighted average fair values of RSUs granted during the six month periods ended June 30, 2019 and 2018 were $7.70 and $19.62 per share, respectively. f. The following table summarizes the departmental allocation of the Company's share-based compensation charges: Six months ended 2019* 2018* Unaudited Cost of revenues $ 95 $ 77 Research and development, net 357 411 Sales and marketing 330 462 General and administrative 183 392 $ 965 $ 1,342 (*) Including $772 and $827 of compensation cost related to RSUs for the six month periods ended June 30, 2019 and 2018, respectively. g. Share-based compensation: As of June 30, 2019, there are $2,749 of total unrecognized costs related to non-vested share-based compensation and RSUs that are expected to be recognized over a weighted average period of 1.13 years. |